White label – Pompe disease - ClinicalTrials.eu

Long-Term Safety Study of Fenfluramine for Patients with Myoclonic Astatic Epilepsy (Doose Syndrome)

Not recruiting

2 1 1 1
Investigated Diseases:
- Epilepsy with myoclonic-atonic seizures
Investigated Drugs:
- Fenfluramine Hydrochloride
Study on Preoperative Treatment with Gemcitabine, Cisplatin, Durvalumab, and Tremelimumab for Patients with Intrahepatic Cholangiocarcinoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Cholangiocarcinoma
Investigated Drugs:
Study on Low-Dose Atropine Sulfate Eye Drops for Controlling Progressive Myopia in Caucasian Children

Not recruiting

3 1
Investigated Diseases:
- Myopia
Investigated Drugs:
- Atropine Sulfate
Study on Improving Survival in Acute Myeloid Leukemia for Adults Aged 18-60 Using Idarubicin, Daunorubicin, Cytarabine, and Mycophenolic Acid

Not recruiting

4 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Cytarabine
- Venetoclax
Study on Liver Transplantation: Comparing Custodiol-N Solution with a Drug Combination for Organ Preservation in Patients Undergoing Liver Transplant Surgery

Not recruiting

3 1 1 1
Investigated Diseases:
- Liver transplant
Investigated Drugs:
Study on the Effects of Buspirone Hydrochloride for Patients with Weak or Absent Esophageal Motility

Not recruiting

3 1 1
Investigated Diseases:
- Gastrointestinal motility disorder
Investigated Drugs:
- Buspirone Hydrochloride
Study on Dupilumab for Treating Nummular Eczema in Patients

Not recruiting

2 1 1 1
Investigated Drugs:
- Dupilumab
Study on the Effectiveness and Safety of Cenerimod for Adults with Moderate to Severe Systemic Lupus Erythematosus

Not recruiting

3 1
Investigated Diseases:
- Systemic lupus erythematosus
Investigated Drugs:
- Cenerimod
Study on Cognitive Function in Liver Transplant Patients Comparing Once-Daily and Twice-Daily Tacrolimus Formulations

Not recruiting

3 1 1 1
Investigated Diseases:
- Liver transplant
Investigated Drugs:
- Tacrolimus
Study on the Safety and Effectiveness of Volrustomig with a Drug Combination for Patients with Solid Tumors

Not recruiting

2 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies